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Objective: Conﬂicting associations between imaging biomarkers and pain in knee osteoarthritis (OA) have
been reported. A relation between pain and denuded areas of subchondral bone (dABs) has been sug-
gested and this study explores this relationship further by relating the presence, phenotype, location and
size of dABs to different measures of knee pain.
Methods: 633 right knees from the Osteoarthritis Initiative (OAI) (250 men, age 61.7  9.6 yrs, BMI
29.4  4.7 kg/m2) were included. Manual segmentation of the femorotibial cartilage plates was per-
formed on 3 T coronal fast low angle shot with water excitation (FLASHwe) images. dABs were deﬁned as
areas where the subchondral bone was uncovered by cartilage. The following measures of pain were
used: weightbearing-, non-weightbearing-, moderate-to-severe-, infrequent- and frequent knee pain.
Results: Using pain measures from subjects without dABs as a reference, those with at least one dAB
had a 1.64-fold higher prevalence ratio [PR, 95% conﬁdence interval (CI) 1.24e2.18] to have frequent and
1.45-fold higher for moderate-to-severe knee pain (95% CI 1.13e1.85). Subjects with dABs in central
subregions had a 1.53-fold increased prevalence of having weightbearing pain (95% CI 1.20e1.97),
especially when the central subregion was moderately (>10%) denuded (PR 1.81, 95% CI 1.35e2.42).
Individuals with cartilage-loss-type dABs had a slightly higher prevalence (PR 1.13, 95% CI 1.00e1.27) of
having frequent knee pain compared to individuals with intra-chondral-osteophyte-type dABs.
Conclusion: This study supports a positive relation between femorotibial dABs and knee pain, especially
when the dABs are located centrally (i.e., in weightbearing regions) or when the respective central
subregion is moderately denuded.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) accounts for a large proportion of the global
disease burden in the industrialized world1 and is most commonly
seen in the knee joint. Among individuals with knee OA, pain is theto: S. Cotofana, Institute of
ergasse 21, A5020 Salzburg,
002-1249.
otofana).
eneva, Switzerland.
s Research Society International. Pmain reason for seekingmedical care2 however, pain perception is a
multifactorial and complex issue3e7. Pain in knee OA likely origi-
nates from richly innervated structures such as the joint capsule8,
the synovium9 or the subchondral bone10 and consequently, pa-
thologies affecting these structures have been suggested to be
directly or indirectly related to pain in knee OA11e15. Several studies
have correlated imaging biomarkers, such as bone marrow lesions
(BMLs), meniscal tears or synovitis, to the incidence and the
severity of ipsi-lateral knee pain in OA12,16e21 however, few suc-
ceeded in ﬁnding signiﬁcant associations16,19e21.ublished by Elsevier Ltd. All rights reserved.
S. Cotofana et al. / Osteoarthritis and Cartilage 21 (2013) 1214e1222 1215Magnetic resonance imaging (MRI) provides several quantitative
structural measures of cartilage morphology22. Denuded areas of
subchondral bone (dABs) are deﬁned as areaswhere the subchondral
bone is not covered by articular cartilage andwas presented as one of
the three variables providing independent information on progres-
sive cartilage loss23. Previous histopathological and immunohisto-
chemical studies in both animals and humans revealed evidence for
the presence of sensory nerve ﬁbres in layers of cartilage next to the
subchondralbone10,24e26. Itwashypothesized, thatnerveﬁbres could
be growing from the subchondral bone (along with blood vessels)
into the non-calciﬁed cartilage during osteochondral remodelling
due to OA progression24. The authors suggest that this neurogenesis
may represent a new potential source of pain, occurring when sub-
chondral bone is exposed to mechanical stimuli due to a lack of
overlaying cartilage. In support, the presence of dABs in OA affected
kneeswas shown to be associatedwith the prevalence and incidence
of knee pain, also after adjustment for BMLs14. Our group recently
showed a signiﬁcant positive relationship between the grade of
radiographic OA (ROA) and the presence of dABs27, and this agrees
well with the report of a positive relationship between individual
radiographic features of OA progression [such as advanced Kellgren
and Lawrence grades (KLG)] and knee pain17.
In a previous report from the sample used in this study, we
identiﬁed at least two different phenotypes of dABs: cartilage-loss-
type and intra-chondral-osteophyte-type (Fig. 1)27. We have also
shown that dABs occur both in the central (i.e., weightbearing) and
the peripheral (non-weightbearing) regions of the knee27, which
may be of importance for knee pain experiences during weight-
bearing and/or non-weightbearing activities. Thus, the presence,
location, size, and phenotype of dABs in the femorotibial joint could
lead to different aspects of knee pain experiences in OA.
The objective of this cross-sectional study was therefore to
investigate the relationship between the presence, location, sizeFig. 1. Different phenotypes of the dABs as visualized quantitatively by MRI cartilage morph
tibia (MT) with (A) and without (B) segmentation. (C & D) intra-chondral-osteophyte-typeand phenotype of dABs and aspects of knee pain (weightbearing-,
non-weightbearing-,moderate-to-severe-, infrequent- and frequent
knee pain). We speciﬁcally hypothesized that individuals with at
least one femorotibial dAB are more likely to experience frequent
pain and have a greater risk of reporting moderate-to-severe knee
pain than individuals without femorotibial dABs, that individuals
with at least one centrally located dAB report more weightbearing
knee pain than individuals with peripheral dABs (whereas the
location is less important in context of non-weightbearing pain)
and that individuals with at least one cartilage-loss-type dAB
are more likely to report frequent pain and have a greater risk of
having moderate-to-severe pain than subjects with intra-chondral-
osteophyte dABs alone.Methods
Study sample
The Osteoarthritis Initiative (OAI) is a large cohort study aiming
to identify biomarkers of OA. The sample analyzed in this study was
based on a convenience sample of OAI participants from industry
partners, the OAI coordinating centre and an image analysis com-
pany (Chondrometrics GmbH). We used baseline knee MRIs from
633 OAI subjects, including participants from the healthy reference
cohort, from the progression cohort, and from the incidence cohort.
The radiographic grading relied on the baseline calculated KLG,
derived from osteophyte and joint space narrowing (JSN) grades as
determined by the Osteoarthritis Research Society International
(OARSI)-atlas scores assigned by centrally trained and certiﬁed
readers at the clinical OAI recruitment sites28. The study sample
and a detailed description of how calculated KLGs were derived
have been previously described in detail27.ometry. (A & B) cartilage-loss-type dAB in the central medial femur (cMF) and medial
dAB in the lateral tibia (LT) with (C) and without (D) segmentation.
S. Cotofana et al. / Osteoarthritis and Cartilage 21 (2013) 1214e12221216In summary: 158 right knees with KL grading, ranging from 0 to
4 from the OAI progression subcohort; 418 right knees with deﬁnite
radiographic knee OA corresponding to KLG 2 and 3; 13 right knees
with radiographic knee OA corresponding to KLG 4; 44 right knees
from the healthy reference cohort without symptomatic or radio-
graphic knee OA (corresponding to KLG 0)27.
Demographic and radiographic data was obtained from the OAI
public database (version 0.2.2 for clinical data and version 0.E.1 for
the imaging data, www.oai.ucsf.edu). Grading of radiographic OA
(ROA) relied on calculated KLG, provided by the OAI and aggre-
gated from the clinical site readings of osteophytes and JSN ac-
cording to the OARSI atlas for the purpose of recruitment28. Table I
shows demographic data of the total sample stratiﬁed by location
and size of the dABs (no dABs, peripheral dABs, central dABs).
Knees with central dABs were further divided into mildly denuded
(denuded area more than 0% but 10% of the respective central
cartilage subregions) and moderately denuded (denuded area
>10% of the respective central cartilage subregions) as described
below.MRI assessment and analysis
This study relied on the double oblique coronal 3D fast lowangle
shot (FLASH) images with water excitation (we), acquired in the
right knees of all OAI participants in this study27, as the FLASHwe
sequence was appropriately validated for articular cartilage anal-
ysis using morphometry, with testeretest precision error for
analyzing dABs of 6.8% [expressed as root mean square of standard
deviations (SDs)]29e31. Quality control as well as the manual seg-
mentation process performed at the image analysis centre (Chon-
drometrics GmbH, Ainring, Germany) was described in detail
previously27,32e34. Data was handled blinded to the aims of this
study and to clinical and radiographic data.Table I
Demographic data, stages of ROA and the presence, location, size and phenotype of dABs i
size of the respective cartilage plate) and moderately denuded (deﬁned as >10% in size
Demographics
(total sample size: n ¼ 633)*
No dABs
(n ¼ 388)
Peripheral dA
(n ¼ 120)
Age, mean (SD) 60.7 (9.7) 64.2 (8.9)
BMI mean (SD) 29.0 (4.9) 30.4 (4.7)
Sex (male), n (%) 130 (33.5) 58 (48.3)
ROA stagey, n (%)* n[ 388 n[ 120
cKLG 0 46 (11.9) 1 (0.8)
cKLG 1 24 (6.2) 6 (5.0)
cKLG 2 184 (47.4) 51 (42.5)
cKLG 3 131 (33.8) 61 (50.8)
cKLG 4 3 (0.8) 1 (0.8)
Pain measures, n (%)* n[ 388 n[ 120
Weightbearing knee painz 112 (28.9) 39 (32.5)
Non-weightbearing knee painx 49 (12.6) 19 (15.8)
Infrequent knee paink 113 (29.1) 39 (32.5)
Frequent knee pain{ 157 (40.5) 52 (43.3)
Moderate-to-severe knee pain# 96 (24.7) 36 (30.0)
Phenotype of dABs, n (%)* n[ 388 n[ 120
Exclusive cartilage-loss-type dABs 0 22 (18.3)
Exclusive intra-chondral-osteophyte-type dABs 0 88 (73.3)
Cartilage-loss & intra-chondral-osteophyte-type
dABs combined
0 10 (8.3)
* Signiﬁcant difference between groups using KruskaleWallis (age, BMI) or Pearson C
y Assessed by calculated KLG.
z At least moderate pain in one of the WOMAC items: stand, stair, walk.
x At least moderate pain in one of the WOMAC items: sit, lie.
k Knee pain in the past 12 months, but not in most days of a month.
{ Knee pain in most days of a month in the past 12 months.
# At least 4 in the NRS ranging from 0 to 10.Denuded areas of subchondral bone
dABs represent regions of subchondral bone not covered by
articular cartilage. As reported previously in this sample, dABs
could be of two types: cartilage loss or intra-chondral-osteophytes
(Fig. 1)27. Classiﬁcation of type and number of dABs was performed
by two expert readers (SC and RF) in each cartilage plate affected by
dAB. Any discrepancies in classifying dABs were resolved imme-
diately in consensus between the two readers27. Since both types
could occur in one plate (or in one knee) we used the following
categories in our analysis:
 Exclusive cartilage-loss-type dABs ¼ plates or knees with dABs
originating from only cartilage-loss-type dABs
 Exclusive intra-chondral-osteophyte-type dABs ¼ plates or
knees with dABs originating from only intra-chondral-
osteophyte-type dABs
 Combined cartilage-loss & intra-chondral-osteophyte-type
dABs ¼ plates or knees with dABs originating from a combi-
nation of the two types (i.e., cartilage-loss-type and intra-
chondral-osteophyte-type dABs).
None of the individual dABs showed a combination of the two
types and consequently each individual dAB was of one single type.
The size and location of dABs of this sample were determined for
each cartilage plate (medial and lateral tibia and central medial and
lateral femur) using custom software (Chondrometrics GmbH,
Ainring, Germany)27,32,33. In brief, dAB size was determined in
relation to the area of subchondral bone in each cartilage plate and
was expressed in percent. The location was automatically deter-
mined in ﬁve tibial (central, external, internal, anterior, and pos-
terior), and three femoral (central, external, internal) subregions for
the medial and lateral compartment respectively using an algo-
rithm previously described27,32,35. The algorithm did however notn the study sample (n ¼ 633). The last two columns showmildly (deﬁned as 10% in
of the respective cartilage plate) central dABs
Bs Central dABs
(n ¼ 125)
Central dABs mildly
denuded (n ¼ 63)
Central dABs moderately
denuded (n ¼ 62)
62.7 (9.4) 61.5 (9.5) 64.0 (9.2)
29.6 (4.0) 29.2 (4.3) 30.0 (3.8)
62 (49.6) 33 (52.4) 29 (46.8)
n [ 125 n [ 63 n [ 62
0 0 0
4 (3.2) 4 (6.3) 0
24 (19.2) 17 (27.0) 7 (11.3)
69 (55.2) 37 (58.7) 32 (51.6)
28 (22.4) 5 (7.9) 23 (37.1)
n [ 125 n [ 63 n [ 62
54 (43.2) 22 (34.9) 32 (51.6)
24 (19.2) 10 (15.9) 14 (22.6)
33 (26.4) 18 (28.6) 15 (24.2)
77 (61.6) 35 (55.6) 42 (67.7)
51 (40.8) 25 (39.7) 26 (41.9)
n [ 125 n [ 63 n [ 62
36 (28.8) 20 (31.7) 16 (25.8)
36 (28.8) 27 (42.9) 9 (14.5)
53 (42.4) 16 (25.4) 37 (59.7)
hi-Squared test (sex, ROA stage, pain measures and dAB phenotype); P < 0.05.
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tral dABs as dABs affecting one of the four central femorotibial
subregions [central medial and lateral tibia (cMT, cLT) and central
medial central femur and central lateral central femur (ccMF, ccLF)]
with dAB > 0%. Respectively, a dAB was classiﬁed as peripheral,
when NOT affecting one of the four central subregions (dAB¼ 0% in
cMT, cLT, ccMF, ccLF). DABs affecting both subregions (f.i. marginally
located) were classiﬁed as central dAB, when dAB > 0% in cMT, cLT,
ccMF, ccLF, disregarding the extent of affection of the neighbouring
peripheral subregion27,35 (Fig. 3).
To investigate the inﬂuence of size of dABs in the central sub-
regions of knees with deﬁnite dABs, we applied a 10% threshold to
classify between mildly versus moderately denuded central sub-
regions. In knees with deﬁnite central dABs, the central subregion
was considered as moderately denuded when >10% of the
respective cartilage subregion was denuded and mildly denuded
when 10% of the respective cartilage subregion was denuded27.
Assessment of pain measures
Measures of knee pain were obtained from the OAI database
(version 0.2.2) and since all MR images were from right knees, only
pain measures from the right knee were used.
Weightbearing and non-weightbearing pain were assessed us-
ing the pain subscore items of the Western Ontario McMaster
Universities Osteoarthritis Index (WOMAC)36. In agreement with
previous publications15,37, we used the three pain subscore
items: “pain during climbing stairs”; “pain during walking”;
“pain during standing” to assess weightbearing pain and the two
pain subscore items: “pain during sitting”; “pain during lying in
bed” to assess non-weightbearing pain. A score of at least 2 (i.e.,
moderate pain) for each item was regarded as a positive outcome
and a score of less than 2 in any of the items was regarded as a
negative outcome. Positive outcomes for all respective items
were regarded as having weightbearing or non-weightbearing
knee pain whereas at least one negative outcome in any of theFig. 2. Adjusted (age, sex, BMI) PR and the 95% CI for:C ¼ “weightbearing” knee pain;B ¼
and ¼ “moderate-to-severe” knee pain in subjects with at least one femorotibial dAB (n
subregions (10% of the subchondral bone area, n ¼ 63) and moderately denuded central sub
95% CIs. Reference category (set as 1) is those without femorotibial dABs (n ¼ 388).items was regarded as not having weightbearing or non-
weightbearing knee pain15.
Pain severity was evaluated using the numerical rating scale
(NRS) where subjects were asked to grade their knee pain severity
during the last 30 days ranging from 0 (no pain) to 10 (pain as bad
as you can imagine). In agreement with previous reports, we
deﬁned the presence of moderate-to-severe knee pain as ‘yes’ if the
answer was 4 or ‘no’ if the answer was <414,38.
Pain frequency was evaluated using the OAI “baseline symptom
status assessment of the right knee” (P01RKSX, www.oai.ucsf.edu):
0 (no pain inpast 12months); 1 (pain in past 12months but notmost
daysof amonth); 2 (painmostdaysof amonth in thepast12months).
We deﬁned 1 as infrequent knee pain and 2 as frequent knee pain.
Statistical analysis
All statistical analyses were performed using PASW 18 (SPSS Inc,
Chicago, IL). To evaluate the relation between different aspects of
knee pain and dABs we used Poisson-regression-models with robust
variance estimator (Huber/White/sandwich estimator) to calculate
the prevalence with adjustment for age, sex and body mass index
(BMI). Results are presented as prevalence ratio (PR) in combination
with the 95% conﬁdence intervals (CIs). KruskaleWallis testwas used
for comparisons of independent test samples for variables deviating
from a normal distribution. Pearson’s Chi-Squared tests were used to
analyze crosstabulation tables. A signiﬁcant relationwas reported for
P-values less than 5%. Further, a post-hoc approach for multiple
testing using Bonferroni correction was conducted when estimating
the PR for dAB phenotype (P< 0.0125) and dAB location (P< 0.0025).
Results
The knees included in this analysis represent a broad spectrum of
the severity of ROA with most knees having mild to moderate ROA.
Individuals without dABs in their analyzed knee comprised the con-
trol group (n ¼ 388), including 44 individuals from the OAI healthy“non-weightbearing” knee pain;: ¼ ”frequent” knee pain;6 ¼ “infrequent” knee pain
¼ 245), peripheral dABs (n ¼ 120), central dABs (n ¼ 125), mildly denuded central
regions (>10% of the subchondral bone area, n ¼ 62). Bars display the upper and lower
Fig. 3. The femorotibial regions and subregion. (A) Showing the four femorotibial medial and lateral tibia (MT, LT) and (medial and lateral) central femur (cMF, cLF) and the 16
femorotibial subregions (10 tibial and six femoral): external, central, internal, anterior and posterior medial and lateral tibia (eMT, cMT, iMT, aMT, pMT and eLT, cLT, iLT, aLT, pLT) and
external, central, internal central medial and lateral femur (ecMF, ccMF, icMF and ecLF, ccLF, icLF). The central subregions are highlighted in bold. (B) Showing an intra-chondral-
osteophyte-type dAB in the central cMF. (C) Showing a cartilage-loss-type dAB in the central cMF (and MT). (D) Overview of the segmentation displayed in (B), showing the intra-
chondral-osteophyte-type dAB in the central cMF comprising less than 10% of the central subregion. Additionally a small peripheral dAB can be seen in the posterior lateral tibia. (E)
Overview of the segmentation displayed in (C), showing a cartilage-loss-type dAB affecting the central cMF and the external cMF but comprising more than 10% of the central
subregion.
S. Cotofana et al. / Osteoarthritis and Cartilage 21 (2013) 1214e12221218reference cohortwith bilateral KLG0 and no risk factors of knee OA. In
this group, 112 (28.9%) reported weightbearing knee pain, 49 (12.6%)
non-weightbearing knee pain, 96 (24.7%) moderate-to-severe knee
pain, 113 (29.1%) infrequent knee pain and 157 (40.5%) frequent knee
pain, whereas the subset from the healthy reference cohort reported
no pain in all of themeasured pain estimates. Two hundred and forty-
ﬁve participants had at least one dAB in their analyzed knee, with 125
(19.8%) of those having central dABs and with 62 (9.8%) having
moderately denuded central dABs. Of those 93 (38%) reported
weightbearing knee pain, 43 (18%) non-weightbearing knee pain, 87
(36%) reported moderate-to-severe knee pain, 129 (53%) frequent
knee pain and 72 (29%) reported infrequent knee pain (Table I).Pain relationships in those with at least one dAB versus those
without any dABs
Compared to thosewithout dABs in the femorotibial joint (Fig. 2),
participants with at least one femorotibial dAB had a higher preva-
lence to report weightbearing knee pain (PR 1.29, 95% CI 1.03e1.61),Table II
Relationship between location (peripheral vs central) and size (mildly vs moderately de
adjustment for age, sex, BMI. The last two columns showmildly (deﬁned as 10% in size o
the respective cartilage plate) central dABs
Pain measures Reference: peripheral
dABs* (n ¼ 120)
Central dABsy
PR (95% CI)
Weightbearing knee pain
P-value (crude)
1 1.40 (1.02e1.9
0.039
Non-weightbearing knee pain
P-value (crude)
1 1.29 (0.74e2.2
0.386
Moderate-to-severe knee pain
P-value (crude)
1 1.41 (1.01e1.9
0.046
Infrequent knee pain
P-value (crude)
1 1.08 (0.94e1.2
0.279
Frequent knee pain
P-value (crude)
1 1.19 (1.06e1.3
0.004
* Knees with at least one dAB not including a central subregion in any of the four car
y Knees with at least one dAB affecting one central subregion of the femorotibial joint
z Knees with at least one dAB affecting at least one central subregion where 10% of
x Knees with at least one dAB affecting at least one central subregion where >10% ofmoderate-to-severe knee pain (PR 1.45, 95% CI 1.13e1.85), infrequent
knee pain (PR 1.50, 95% CI 1.11e2.03) and frequent knee pain (PR 1.64,
95% CI 1.24e2.13). The prevalence of non-weightbearing knee pain
was not signiﬁcantly higher in those with at least one femorotibial
dAB, compared to those without dABs (PR 1.37, 95% CI 0.93e2.01).
Compared to those without dABs, those with at least one dAB in the
central subregions were more prevalent to have weightbearing knee
pain (PR 1.53, 95% CI 1.20e1.97), moderate-to-severe knee pain (PR
1.67, 95% CI 1.27e2.19), infrequent knee pain (PR 2.11, 95% CI 1.20e
3.71) and frequent knee pain (PR 2.93, 95% CI 1.74e4.94) (Fig. 2). No
statistically signiﬁcant relationship for any pain measure was found
between participants with only peripheral dABs when compared to
participants without any dABs (P > 0.11; Fig. 2).Pain relationships with regard to location, size and phenotype of
dAB in those with dABs
Using individuals with peripheral dABs as reference, individuals
with at least one central dAB had a higher prevalence of havingnuded) of dABs within those with dABs (n ¼ 245). Values are presented as PR with
f the respective cartilage plate) and moderately denuded (deﬁned as >10% in size of
(n ¼ 125) Mildly denuded central
subregionz (n ¼ 63)
PR (95% CI)
Moderately denuded central
subregionx (n ¼ 62)
PR (95% CI)
3) 1.20 (0.80e1.81)
0.382
1.62 (1.15e2.30)
0.006
4) 1.80 (0.54e2.18)
0.827
1.49 (0.80e2.77)
0.206
7) 1.43 (0.97e2.11)
0.071
1.41 (0.94e2.11)
0.094
3) 1.01 (0.88e1.17)
0.845
1.20 (0.94e1.54)
0.151
4) 1.11 (0.97e1.27)
0.133
1.48 (1.19e1.85)
<0.001
tilage plates.
.
the central subregion is denuded (mildly denuded).
one central subregion is denuded (moderately denuded).
Table III
Relationship between size (mildly vs moderately denuded) of centrally located dABs
within those with central dABs exclusively (n ¼ 125). Values are presented as PR
with adjustment for age, sex, BMI
Reference: Mildly
denuded central
subregions*
(n ¼ 63)
Moderately denuded
central subregionsy
(n ¼ 62)
PR (95% CI)
Weightbearing knee pain
P-value (crude)
1 1.45 (0.97e2.18)
0.071
Non-weightbearing knee pain
P-value (crude)
1 1.46 (0.70e3.02)
0.313
Moderate-to-severe knee pain
P-value (crude)
1 1.07 (0.71e1.61)
0.766
Infrequent knee pain
P-value (crude)
1 1.07 (0.95e1.21)
0.275
Frequent knee pain
P-value (crude)
1 1.11 (0.99e1.24)
0.073
* Knees with at least one dAB affecting at least one central subregion where 10%
of the central subregion is denuded (mildly denuded).
y Knees with at least one dAB affecting at least one central subregion where >10%
of one central subregion is denuded (moderately denuded).
S. Cotofana et al. / Osteoarthritis and Cartilage 21 (2013) 1214e1222 1219weightbearing knee pain (PR 1.40, 95% CI 1.02e1.93), moderate-to-
severe knee pain (PR 1.41, 95% CI 1.01e1.97) and frequent knee pain
(PR 1.19, 95% CI 1.06e1.34) (Table II). Further, thosewith at least one
moderately denuded central subregion had a higher prevalence to
report weightbearing pain (PR 1.62, 95% CI 1.15e2.30) and frequent
knee pain (PR 1.48, 95% CI 1.19e1.85) (Table II) compared to in-
dividuals with peripheral dABs.
No statistical signiﬁcant relationships were seen between in-
dividuals with mildly denuded central subregions compared to
individuals with moderately denuded central subregions. However,
a trend was visible for individuals with moderately denuded cen-
tral areas towards a higher prevalence of reporting weightbearing
and frequent knee pain (Table III).
With regard to dAB phenotypes, participants with combined
cartilage-loss-type and intra-chondral-osteophyte-type dABs in the
femorotibial joint had a slightly higher prevalence of reporting
frequent knee pain compared to individuals with exclusive intra-
chondral-osteophyte-type dABs (PR 1.13, 95% CI 1.00e1.27, not
signiﬁcant after correction for multiple testing) (Table IV).
On the cartilage plate level, individuals with a dAB in the central
medial femur (PR 1.22, 95% CI 1.08e1.38) and in the lateral tibia (PR
1.15, 95% CI 1.02e1.30, not signiﬁcant after correction for multiple
testing) had an increased prevalence to report frequent knee pain.
Remarkably, individuals with a dAB in the central lateral femur
were less prevalent to report non-weightbearing knee pain (PRTable IV
Relationship between different phenotypes (cartilage-loss-type vs intra-chondral-osteoph
adjustment for age, sex, BMI
Reference: Exclusive
intra-chondral-osteophyte-type
dAB* (n ¼ 124)
Weightbearing knee pain
P-value (crude)
1
Non-weightbearing knee pain
P-value (crude)
1
Moderate-to-severe knee pain
P-value (crude)
1
Infrequent knee pain
P-value (crude)
1
Frequent knee pain
P-value (crude)
1
* Knees with at least one intra-chondral-osteophyte-type dAB (not combined with ca
y Knees with at least one cartilage-loss-type dAB (not combined with intra-chondral-
z Knees with at least one cartilage-loss-type dAB (including the possibility of a combi0.51, 95% CI 0.26e0.97, not signiﬁcant after correction for multiple
testing) compared to those with a dAB in any other plate (Table V).Discussion
To our knowledge, this is the ﬁrst study to assess the cross-
sectional relationship between the presence, location, the size
and the phenotype of femorotibial dABs and different aspects of
knee pain. Using a larger sample, this study conﬁrms a positive
relation between femorotibial dABs and ipsi-lateral knee pain,
previously shown by Moisio et al.14 In extension of that report
however, our results also suggest that those with at least one dAB
report more weightbearing pain, but not more non-weightbearing
knee pain, than subjects without dABs and that individuals with
central dABs (i.e., dABs affecting at least one weightbearing sub-
region) report more weightbearing, moderate-to-severe, and
frequent knee pain than those with peripheral dABs, especially
when more than 10% of the central subregion was denuded.
This study has certain limitations. First, cross-sectional pain
assessment is a challenge, mainly due to the large individual vari-
ation inﬂuenced by multiple endogenous and exogenous factors in
the subjective pain experience3e7. However, we used a standard
deﬁnition for the assessment of frequency of knee pain, a previ-
ously published strategy to assess knee pain during (femorotibial)
weightbearing and non-weightbearing conditions, and an estab-
lished classiﬁcation for the absence/presence of moderate-to-
severe knee pain15,37,38. It is noteworthy, that pain during sitting,
classiﬁed here as non-weightbearing knee pain, could originate
from femoropatellar joint disease but evaluation of the femo-
ropatellar compartmentwas technically not possible from a coronal
FLASHwe imaging protocol, which was the basis of the current
analysis. Secondly, dAB is an MR imaging ﬁnding derived from
manual segmentation of cartilage and subchondral bone and may
not directly relate to clinically relevant ﬁndings reported by expe-
rienced radiologists or to focal chondral defects seen at arthros-
copy. Thirdly, the MR sequence used here (FLASHwe) does not
adequately visualize other relevant joint pathologies, such as BMLs,
meniscal tears or synovitis, previously shown to have a relation to
knee pain in OA12,16e21. However, appropriate sequences were ac-
quired by the OAI but since we concentrated on the FLASHwe
sequence we lack information on other joint pathologies and have
not assessed their potential relation to pain in this sample. Future
work is needed to light up to what extent these and dABs are
correlated and/or provide independent information.
We are aware of one publication reporting associations be-
tween dABs and knee pain where knees with dABs larger than theyte-type) of dABs within those with dABs (n¼ 245). Values are presented as PR with
Exclusive cartilage-loss-type
dABsy (n ¼ 58)
PR (95% CI)
Unspeciﬁc cartilage-loss-type
dABsz (n ¼ 121)
PR (95% CI)
1.22 (0.80e1.86)
0.359
1.35 (0.98e1.87)
0.066
1.80 (0.91e3.55)
0.090
1.58 (0.88e2.84)
0.129
1.20 (0.80e1.81)
0.382
1.08 (0.77e1.52)
0.641
0.98 (0.85e1.13)
0.745
1.07 (0.94e1.22)
0.341
1.00 (0.88e1.14)
0.950
1.13 (1.00e1.27)
0.050
rtilage-loss-type dABs) in the femorotibial joint.
osteophyte-type dABs) in the femorotibial joint.
nation of cartilage-loss-type and intra-chondral-osteophyte-type dABs).
Table V
Relationship between location (medial and lateral tibia and central femur) of dABs within those with dABs (n ¼ 245). Values are presented as PR with adjustment for age, sex,
BMI. Reference groups were those with at least one dAB in the femorotibial joint but without any dAB in the respective cartilage plate
Reference: No dAB
in cMF (n ¼ 151)
At least one
dAB in cMF
(n ¼ 94)
PR (95% CI)
Reference: No dAB
in cLF (n ¼ 156)
At least one
dAB in cLF
(n ¼ 89)
PR (95% CI)
Weightbearing knee pain
P-value (crude)
1 1.28 (0.94e1.76)
0.119
1 0.99 (0.71e1.36)
0.931
Non-weightbearing knee pain
P-value (crude)
1 1.20 (0.70e2.05)
0.517
1 0.51 (0.26e0.97)
0.040
Moderate-to-severe knee pain
P-value (crude)
1 1.16 (0.83e1.61)
0.396
1 0.99 (0.70e1.39)
0.931
Infrequent knee pain
P-value (crude)
1 1.13 (0.99e1.29)
0.076
1 0.92 (0.81e1.06)
0.246
Frequent knee pain
P-value (crude)
1 1.22 (1.08e1.38)
0.001
1 0.95 (0.84e1.07)
0.355
Reference: No
dAB in MT (n ¼ 155)
At least one dAB
in MT (n ¼ 90)
PR (95% CI)
Reference: No dAB
in LT (n ¼ 129)
At least one dAB
in LT (n ¼ 116)
PR (95% CI)
Weightbearing knee pain
P-value (crude)
1 1.23 (0.90e1.69)
0.203
1 1.09 (0.80e1.49)
0.588
Non-weightbearing knee pain
P-value (crude)
1 1.65 (0.96e2.83)
0.071
1 0.87 (0.51e1.50)
0.662
Moderate-to-severe knee pain
P-value (crude)
1 1.31 (0.94e1.82)
0.113
1 0.95 (0.68e1.32)
0.746
Infrequent knee pain
P-value (crude)
1 1.00 (0.88e1.15)
0.950
1 1.13 (0.99e1.29)
0.076
Frequent knee pain
P-value (crude)
1 1.06 (0.93e1.20)
0.371
1 1.15 (1.02e1.30)
0.024
cMF/cLF ¼ central medial/lateral femur.
S. Cotofana et al. / Osteoarthritis and Cartilage 21 (2013) 1214e12221220median size in the patellar and the medial, but not the lateral,
femorotibial compartment had more frequent and moderate-to-
severe knee pain than those without dABs, also after adjusting
for age, sex, BMI and the presence of BMLs 14. The previous study
and our study were similar in the cross-sectional design and in the
methodology used to detect and quantify dABs however, our
sample size was three times larger, we used a more detailed
description of dABs and we extended the pain analysis. In agree-
ment with Moisio et al.14, we found a signiﬁcant relation between
frequent and moderate-to-severe ipsi-lateral knee pain and a
presence of dABs however, we found this relation regardless of
dAB size. In extension of previous ﬁndings, we could also identify a
relation between weightbearing, but not non-weightbearing knee
pain in those with dABs. Interestingly, the relation between all
measures of knee pain, except non-weightbearing knee pain, was
stronger when the dAB was located in a central (i.e., weightbear-
ing) subregion and when more than 10% of the central subregion
was denuded. These ﬁndings are interesting since it is well known
that articular cartilage is aneural and thereby insensate to me-
chanical stimuli39. It is also unclear whether intra-chondral-
osteophytes are formed by protrusion of the richly innervated
subchondral bone or if they are formed by other processes.
Although neurovascular invasion of osteophytes were suggested in
OA10, ﬁrm relations between the presence of osteophytes and ipsi-
lateral knee pain are lacking17,19,40e42. On the other hand, sub-
chondral bone has been shown to undergo osteochondral turnover
with sensory nerve ﬁbres breaching from the subchondral bone
into adjacent layers of non-calciﬁed articular cartilage during OA
progression10,24e26 and the mechanism driving pain remains un-
clear. It is also not known whether dABs in fact contribute to the
pain experience or if they are a manifestation of disease severity,
relating to knee pain only indirectly. Still, the positive relationship
between dABs and ipsi-lateral knee pain found here, and before14,
suggests that dABs may play one role for different aspects of knee
pain in OA however, properly designed longitudinal studies need
to conﬁrm such relations.Cartilage-loss-typedABs, as visualized onMR images,were shown
to be highly associated with knee pain in both young and elderly
individuals43,44. Moreover, our study shows that subjects with
moderately denuded central subregions have a higher prevalence of
reportingweightbearing, but not non-weightbearing, knee pain than
do individuals with only peripheral dABs. Such prevalence was
however not found when comparing individuals with moderately
and mildly denuded central subregions. This ﬁnding is interesting
since central subregions of the femorotibial joint aremore exposed to
peak loads under weightbearing conditions22,45, in part due to the
lack of the protectivemeniscal tissue. One possible explanation could
be that pain is produced from the exposed subchondral bone, inde-
pendent of the size of the dAB, which may explain the reduced
mobility and the limited range of motion seen in knee OA patients.
The results of this study generate the hypothesis that both pheno-
types and the location (but not the size) of dABs play a role in OA
related knee pain.
Having dABs in the central medial femur, but not in any other
cartilage plate, slightly increased the prevalence of frequent knee
pain compared to having a dAB at another location. The central
medial femur was not the plate most frequently affected by dABs27,
but interestingly, this speciﬁc location was reported to show the
greatest longitudinal change in cartilage thickness and volume
amongst the femorotibial cartilage plates33,46,47. In addition, the
central medial femurwas reported to display cartilage thickening at
early stages of OA disease, particularly in the external subregion48.
Although no linkage between pain and cartilage morphology
changes has been established, our results agree with other reports
in suggesting that the central medial femur might be an important
location in knee OA.
Conclusion
This study conﬁrms, in a large sample, the association between
the presence of dABs and various important aspects of ipsi-lateral
knee pain. One must keep in mind that some of the subjects
S. Cotofana et al. / Osteoarthritis and Cartilage 21 (2013) 1214e1222 1221without dABs also suffered from knee pain; clearly, therefore, a
number of reasons (not all studied here) exist why some have or
develop knee pain. However, the purpose of the currentworkwas to
focus on dABs, a relatively novel structural correlate of pain. Our
extended analysis suggests that subjects with femorotibial dABs
encounter signiﬁcantly more frequent, more moderate-to-severe,
and speciﬁcally more weightbearing ipsi-lateral knee pain than
those without dABs. This relationship appears to be stronger for
dABs located in central subregions and for dABs coveringmore than
10% of a central subregion. Finally, presence of cartilage-loss-type
dABs seems to increase the likelihood of frequent ipsi-lateral knee
pain, compared to that of intra-chondral-osteophyte-type dABs.
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